文献速递神经肿瘤小儿神经外科与脑积水

顶盖板胶质瘤伽玛刀放射外科治疗后的反应模式

Patterns of response following gamma knife radiosurgery for tectal plate gliomas.
PubMed 文献 · J Neurooncol · 2025-04-09

该回顾性研究分析2014年1月至2023年11月在一家三级伽玛刀中心接受伽玛刀放射外科治疗的10例顶盖板胶质瘤患者,评估影像学反应模式和临床结局。中位随访24个月,90%病例肿瘤逐渐缩小,中位体积缩小56.7%,80%患者症状改善,4例出现以头痛为主的轻微不良反应。作者认为伽玛刀放射外科是安全有效的治疗选择,主要用于手术不可行时。

要点

  • 10例顶盖板胶质瘤患者接受伽玛刀放射外科,中位年龄13岁,中位肿瘤体积2.18 cc。
  • 中位随访24个月,90%病例肿瘤逐渐缩小,中位体积缩小56.7%,1例出现假性进展。
  • 80%患者症状改善,20%保持稳定,4例出现以头痛为主的轻微不良反应。

核心结论

  • 伽玛刀放射外科是顶盖板胶质瘤安全有效的治疗方法,可提供显著的肿瘤控制且并发症轻微。
  • 其主要导致肿瘤逐渐缩小,当手术不可行时可作为可行替代方案。

研究设计与样本

  • 回顾性分析2014年1月至2023年11月在一家三级伽玛刀中心接受伽玛刀放射外科治疗的10例顶盖板胶质瘤患者。
  • 纳入标准要求至少1年随访并有影像学评估。
  • 记录肿瘤体积、剂量参数、影像学反应和临床结局。

主要发现

  • 队列包括6例女性和4例男性,中位年龄13岁(范围2-31岁)。
  • 脑积水通过内镜下第三脑室造瘘术(50%)或脑室腹腔分流术(40%)管理。
  • 40%病例有组织病理学确认,显示WHO 2级弥漫性星形细胞瘤。
  • 中位肿瘤体积2.18 cc,边缘剂量12 Gy,50%等剂量线。
  • 影像学随访(中位24个月)显示90%病例肿瘤逐渐缩小,中位体积缩小56.7%;1例出现假性进展,未观察到囊性变或持续肿瘤生长。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Tectal plate gliomas are slow-growing brainstem tumors often causing obstructive hydrocephalus. This study evaluates radiological response patterns and clinical outcomes of Gamma Knife radiosurgery (GKRS), a minimally invasive alternative for tumor control with lower risks than surgery. METHODS: A retrospective analysis was conducted on 10 patients treated with GKRS for tectal plate gliomas between January 2014 and November 2023 at a tertiary Gamma Knife Centre. Inclusion criteria required a minimum follow-up of one year with radiological assessment. Tumor volume, dose parameters, radiological responses, and clinical outcomes were documented. RESULTS: The cohort comprised six females and four males, with a median age of 13 years (range: 2-31 years). Hydrocephalus was managed with endoscopic third ventriculostomy (50%) or ventriculoperitoneal shunting (40%). Histopathological confirmation, available in 40% of cases, revealed WHO Grade 2 diffuse astrocytoma. The median tumor volume was 2.18 cc, and a marginal dose of 12 Gy was delivered at a 50% isodose line. Radiological follow-up (median: 24 months) demonstrated a gradual reduction in tumor size in 90% of cases, with a median volume reduction of 56.7%. One patient exhibited pseudoprogression, and no cases of cystic degeneration or sustained tumor growth were observed. Clinically, 80% of patients reported symptomatic improvement, while 20% remained stable. Minor adverse effects, primarily headaches, were noted in four patients. CONCLUSION: GKRS is a safe, effective treatment for tectal plate gliomas, offering significant tumor control with minimal complications. It primarily results in gradual tumor shrinkage, making it a viable alternative when surgery is not feasible.

来源:J Neurooncol,查看原文。版权归原作者所有。

引用

  1. Pandey K, Mishra S, Garg K, et al. Patterns of response following gamma knife radiosurgery for tectal plate gliomas. J Neurooncol. 2025. PMID: 40202567. doi:10.1007/s11060-025-05034-9

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。